Visual search speed, scanning, and processing speed were assessed using Trail Making A. The authors recommended that sarcopenia and sarcopenic obesity should be regarded as clinical indicators of cognitive impairment, listing potential mechanisms that explain sarcopenic obesity and cognitive deficits association, including low-grade chronic inflammation, oxidative stress, and insulin resistance; however, no biomarker data was included in the report. This evidence concerns the gene INS and Cognitive impairment.